Skip to main content
OpenTrials
Completed

NCT Number: NCT01039662

Reduction of the Dietary Glycemic Index (GI) by L-Arabinose and Indigestible Dextrin

This study aims to investigate the effect of supplement containing L-arabinose and indigestible dextrin on dietary glycemic index.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

20 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hiroshima University

Hiroshima, 734-8551, Japan

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy as based on medical history and physical examination
  • BMI is less or equal to 30 kg/m2
  • Willing not to serve as blood donor during the study
  • Informed consent signed

Exclusion criteria

  • Impaired Glucose Tolerance
  • Female subjects who are pregnant or nursing a child
  • Participation in any clinical trial up to 90 days before Day 1 of this study
  • Renal or hepatic dysfunction
  • Heart disease
  • Under medication

Treatment and study plan

L-arabinose and indigestible dextrin

Dietary Supplement

Placebo

Dietary Supplement

Primary outcomes

  1. Postprandial glucose level

    Time frame: 2 hours

Sponsors and collaborators

Lead sponsor

Hiroshima University

Other

Collaborators

  • Unitika Ltd.

Registry information

Official study title

Effects of the Combination of L-Arabinose and Indigestible Dextrin on Glycemic Index: a Double-Blind, Crossover Trial

Important dates

Study start
2009
Primary completion
2010
Study completion
2010
First posted
Dec 25, 2009
Registry last updated
Jun 23, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.